RIVAROXABAN: AN ORAL DIRECT INHIBITOR OF FACTOR X-A. International Research Journal of Pharmacy, [S. l.], v. 2, n. 8, p. 1–5, 2024. Disponível em: https://irjponline.org/index.php/irjp/article/view/1833. Acesso em: 4 nov. 2026.